FIND

researchers

DISCOVER

relevant articles

PROMOTE

your research

now for free

Richard Heyman

Research Profile

Chemicals & Drugs

Living Beings

Mouse
Rats

Physiology

Anatomy

Concepts & Ideas

Molecular Sequence Data

Co-author Network

Publications

TOP 3
Mark D Leibowitz; Robert J Ardecky; Marcus F Boehm; Carol L Broderick; Mark A Carfagna; Diane L Crombie; Jennifer D'Arrigo; Garret J Etgen; Margaret M Faul; Timothy Grese; Henry Havel; Nancy I Hein; Richard A Heyman; Diane Jolley; Kay Klausing; Sha Liu; Dale E Mais; Christopher M Mapes; Keith B Marschke; Pierre-Yves Michellys; Chahrzad Montrose-Rafizadeh; Kathleen M Ogilvie; Bernadette Pascual; Deepa Rungta; John S Tyhonas; Mary S Urcan; Marilyn Wardlow; Nathan Yumibe; Anne Reifel-Miller
Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.
Nancy Levin; Eric D Bischoff; Chris L Daige; Diane Thomas; Calvin T Vu; Richard A Heyman; Rajendra K Tangirala; Ira G Schulman
Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists.
Patricia J Willy; Ian R Murray; Jing Qian; Brett B Busch; William C Stevens; Richard Martin; Raju Mohan; Sihong Zhou; Peter Ordentlich; Ping Wei; Douglas W Sapp; Robert A Horlick; Richard A Heyman; Ira G Schulman
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand.

Register for free to view:

Visualized networks:

See your personal network in
sophisticated graphical views

GeoTargeted Searches:

Locate experts around the world
and connect with global collaborators

Research Profiles:

See the research activity
of experts around the globe

Geonetwork of Richard Heyman (preview)

Cities where this author has publications
Cities where co-authors of this author have publications

Flash Player Required

All Publications

2006: Mark D Leibowitz; Robert J Ardecky; Marcus F Boehm; Carol L Broderick; Mark A Carfagna; Diane L Crombie; Jennifer D'Arrigo; Garret J Etgen; Margaret M Faul; Timothy Grese; Henry Havel; Nancy I Hein; Richard A Heyman; Diane Jolley; Kay Klausing; Sha Liu; Dale E Mais; Christopher M Mapes; Keith B Marschke; Pierre-Yves Michellys; Chahrzad Montrose-Rafizadeh; Kathleen M Ogilvie; Bernadette Pascual; Deepa Rungta; John S Tyhonas; Mary S Urcan; Marilyn Wardlow; Nathan Yumibe; Anne Reifel-Miller
Biological characterization of a heterodimer-selective retinoid X receptor modulator: potential benefits for the treatment of type 2 diabetes.
Endocrinology 2006;147(2):1044-53.
2005: Nancy Levin; Eric D Bischoff; Chris L Daige; Diane Thomas; Calvin T Vu; Richard A Heyman; Rajendra K Tangirala; Ira G Schulman
Macrophage liver X receptor is required for antiatherogenic activity of LXR agonists.
Arteriosclerosis, thrombosis, and vascular biology 2005;25(1):135-42.
2004: Patricia J Willy; Ian R Murray; Jing Qian; Brett B Busch; William C Stevens; Richard Martin; Raju Mohan; Sihong Zhou; Peter Ordentlich; Ping Wei; Douglas W Sapp; Robert A Horlick; Richard A Heyman; Ira G Schulman
Regulation of PPARgamma coactivator 1alpha (PGC-1alpha) signaling by an estrogen-related receptor alpha (ERRalpha) ligand.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(24):8912-7.
2004: Mara H Rendi; Nanjoo Suh; William W Lamph; Stan Krajewski; John C Reed; Richard A Heyman; Andrew Berchuck; Karen T Liby; Renee Risingsong; Darlene B Royce; Charlotte R Williams; Michael B. Sporn
The selective estrogen receptor modulator arzoxifene and the rexinoid LG100268 cooperate to promote transforming growth factor beta-dependent apoptosis in breast cancer.
Cancer research 2004;64(10):3566-71.
2004: Ira G Schulman; Richard A Heyman
The flip side: Identifying small molecule regulators of nuclear receptors.
Chemistry & biology 2004;11(5):639-46.
2004: Vamsi K Mootha; Christoph Handschin; Dan Arlow; Xiaohui Xie; Julie St Pierre; Smita Sihag; Wenli Yang; David Altshuler; Pere Puigserver; Nick Patterson; Patricia J Willy; Ira G Schulman; Richard A Heyman; Eric S Lander; Bruce M Spiegelman
Erralpha and Gabpa/b specify PGC-1alpha-dependent oxidative phosphorylation gene expression that is altered in diabetic muscle.
Proceedings of the National Academy of Sciences of the United States of America 2004;101(17):6570-5.
2004: Kathleen M Ogilvie; Régis Saladin; Tim Nagy; Mary S Urcan; Richard A Heyman; Mark D Leibowitz
Activation of the retinoid X receptor suppresses appetite in the rat.
Endocrinology 2004;145(2):565-73.
2003: Asa Wallen-Mackenzie; Alexander Mata de Urquiza; Susanna Petersson; Francisco J Rodriguez; Stina Friling; Joseph Wagner; Peter Ordentlich; Johan Lengqvist; Richard A Heyman; Ernest Arenas; Thomas Perlmann
Nurr1-RXR heterodimers mediate RXR ligand-induced signaling in neuronal cells.
Genes & development 2003;17(24):3036-47.
2003: Brandee L Wagner; Annabel F Valledor; Gang Shao; Chris L Daige; Eric D Bischoff; Mary Petrowski; Kristen Jepsen; Sung Hee Baek; Richard A Heyman; Michael G Rosenfeld; Ira G Schulman; Christopher K Glass
Promoter-specific roles for liver X receptor/corepressor complexes in the regulation of ABCA1 and SREBP1 gene expression.
Molecular and cellular biology 2003;23(16):5780-9.
2003: Peter Ordentlich; Yingzhuo Yan; Sihong Zhou; Richard A Heyman
Identification of the antineoplastic agent 6-mercaptopurine as an activator of the orphan nuclear hormone receptor Nurr1.
The Journal of biological chemistry 2003;278(27):24791-9.
2003: Pierre-Yves Michellys; Robert J Ardecky; Jyun-Hung Chen; Diane L Crombie; Garret J Etgen; Margaret M Faul; A L Faulkner; Timothy Grese; Richard A Heyman; Donald S Karanewsky; Kay Klausing; Mark D Leibowitz; Sha Liu; Dale A Mais; Christopher M Mapes; Keith B Marschke; Anne Reifel-Miller; Kathleen M Ogilvie; Deepa Rungta; Anthony W Thompson; John S Tyhonas; Marcus F Boehm
Novel (2E,4E,6Z)-7-(2-alkoxy-3,5-dialkylbenzene)-3-methylocta-2,4,6-trienoic acid retinoid X receptor modulators are active in models of type 2 diabetes.
Journal of medicinal chemistry 2003;46(13):2683-96.
2003: Luc J Farmer; Lin Zhi; Susan Jeong; William W Lamph; Deborah L Osburn; Glenn Croston; Karen S Flatten; Richard A Heyman; Alex M Nadzan
Retinoic acid receptor ligands based on the 6-cyclopropyl-2,4-hexadienoic acid.
Bioorganic & medicinal chemistry letters 2003;13(2):261-4.
2002: Nanjoo Suh; William W Lamph; Andrew Glasebrook; Timothy Grese; Alan D Palkowitz; Charlotte R Williams; Renee Risingsong; M Rendi Farris; Richard A Heyman; Michael B. Sporn
Prevention and treatment of experimental breast cancer with the combination of a new selective estrogen receptor modulator, arzoxifene, and a new rexinoid, LG 100268.
Clinical cancer research : an official journal of the American Association for Cancer Research 2002;8(10):3270-5.
2002: Rajendra K Tangirala; Eric D Bischoff; Sean B Joseph; Brandee L Wagner; Robert Walczak; Bryan A Laffitte; Chris L Daige; Diane Thomas; Richard A Heyman; David J Mangelsdorf; Xuping Wang; Aldons J Lusis; Peter Tontonoz; Ira G Schulman
Identification of macrophage liver X receptors as inhibitors of atherosclerosis.
Proceedings of the National Academy of Sciences of the United States of America 2002;99(18):11896-901.
2002: Li Wang; Yoon-Kwang Lee; Donnie Bundman; Yunqing Han; Sundararajah Thevananther; Chang Soo Kim; Steven S Chua; Ping Wei; Richard A Heyman; Michael Karin; David D Moore
Redundant pathways for negative feedback regulation of bile acid production.
Developmental cell 2002;2(6):721-31.
2002: Nancy L Urizar; Amy B Liverman; D'Nette T Dodds; Frank Valentin Silva; Peter Ordentlich; Yingzhuo Yan; Frank J Gonzalez; Richard A Heyman; David J Mangelsdorf; David D Moore
A natural product that lowers cholesterol as an antagonist ligand for FXR.
Science (New York, N.Y.) 2002;296(5573):1703-6.
2001: Rosemary M Cesario; Kay Klausing; H Razzaghi; Diane L Crombie; Deepa Rungta; Richard A Heyman; Deepak S Lala
The rexinoid LG100754 is a novel RXR:PPARgamma agonist and decreases glucose levels in vivo.
Molecular endocrinology (Baltimore, Md.) 2001;15(8):1360-9.
2001: H Singh Ahuja; Sha Liu; Diane L Crombie; M Boehm; Mark D Leibowitz; Richard A Heyman; Christophe Depre; Laszlo Nagy; Peter Tontonoz; Peter Davies
Differential effects of rexinoids and thiazolidinediones on metabolic gene expression in diabetic rodents.
Molecular pharmacology 2001;59(4):765-73.
2001: T Claudel; Mark D Leibowitz; Catherine Fiévet; Anne Tailleux; B Wagner; Joyce J Repa; Gérard Torpier; Jean-Marc Lobaccaro; James R Paterniti; D J Mangelsdorf; Richard A Heyman; Johan Auwerx
Reduction of atherosclerosis in apolipoprotein E knockout mice by activation of the retinoid X receptor.
Proceedings of the National Academy of Sciences of the United States of America 2001;98(5):2610-5.
2001: Peter Davies; S A Berry; Gregory L Shipley; R H Eckel; Nathalie Hennuyer; Diane L Crombie; Kathleen M Ogilvie; Julia Peinado-Onsurbe; Catherine Fievet; Mark D Leibowitz; Richard A Heyman; Johan Auwerx
Metabolic effects of rexinoids: tissue-specific regulation of lipoprotein lipase activity.
Molecular pharmacology 2001;59(2):170-6.
2000: V Emilsson; Jacqueline O'Dowd; Steven Wang; YL Liu; Matthew V Sennitt; Richard A Heyman; Michael A Cawthorne
The effects of rexinoids and rosiglitazone on body weight and uncoupling protein isoform expression in the Zucker fa/fa rat.
Metabolism: clinical and experimental 2000;49(12):1610-5.
2000: YL Liu; Matthew V Sennitt; DC Hislop; Diane L Crombie; Richard A Heyman; Michael A Cawthorne
Retinoid X receptor agonists have anti-obesity effects and improve insulin sensitivity in Zucker fa/fa rats.
International journal of obesity and related metabolic disorders : journal of the International Association for the Study of Obesity 2000;24(8):997-1004.
2000: Gang Shao; Richard A Heyman; Ira G Schulman
Three amino acids specify coactivator choice by retinoid X receptors.
Molecular endocrinology (Baltimore, Md.) 2000;14(8):1198-209.
2000: G Martin; Hélène Poirier; Nathalie Hennuyer; Diane L Crombie; Jean-Charles Fruchart; Richard A Heyman; Philippe Besnard; Johan Auwerx
Induction of the fatty acid transport protein 1 and acyl-CoA synthase genes by dimer-selective rexinoids suggests that the peroxisome proliferator-activated receptor-retinoid X receptor heterodimer is their molecular target.
The Journal of biological chemistry 2000;275(17):12612-8.
2000: Shi-Yong Sun; Ping Yue; Li Mao; Marcia I Dawson; B Shroot; William W Lamph; Richard A Heyman; Roshantha A S Chandraratna; K Shudo; Waun Ki Hong; Reuben Lotan
Identification of receptor-selective retinoids that are potent inhibitors of the growth of human head and neck squamous cell carcinoma cells.
Clinical cancer research : an official journal of the American Association for Cancer Research 2000;6(4):1563-73.
1999: Eric D Bischoff; Richard A Heyman; William W Lamph
Effect of the retinoid X receptor-selective ligand LGD1069 on mammary carcinoma after tamoxifen failure.
Journal of the National Cancer Institute 1999;91(24):2118.
1999: Marcus F Boehm; P Fitzgerald; Aihua Zou; M G Elgort; Eric D Bischoff; L Mere; Dale E Mais; Reid P Bissonnette; Richard A Heyman; Alex M Nadzan; M Reichman; Elizabeth A Allegretto
Novel nonsecosteroidal vitamin D mimics exert VDR-modulating activities with less calcium mobilization than 1,25-dihydroxyvitamin D3.
Chemistry & biology 1999;6(5):265-75.
1999: Barton S Johnson; R A Chandraratna; Richard A Heyman; Elizabeth A Allegretto; LeMoyne Mueller; S J Collins
Retinoid X receptor (RXR) agonist-induced activation of dominant-negative RXR-retinoic acid receptor alpha403 heterodimers is developmentally regulated during myeloid differentiation.
Molecular and cellular biology 1999;19(5):3372-82.
1999: Stacie S Canan Koch; L J Dardashti; Rosemary M Cesario; Glenn Croston; Marcus F Boehm; Richard A Heyman; Alex M Nadzan
Synthesis of retinoid X receptor-specific ligands that are potent inducers of adipogenesis in 3T3-L1 cells.
Journal of medicinal chemistry 1999;42(4):742-50.
1998: L Solomin; C B Johansson; Rolf H Zetterström; Reid P Bissonnette; Richard A Heyman; Lars Olson; U Lendahl; J Frisén; Thomas Perlmann
Retinoid-X receptor signalling in the developing spinal cord.
Nature 1998;395(6700):398-402.
1998: Ira G Schulman; Gang Shao; Richard A Heyman
Transactivation by retinoid X receptor-peroxisome proliferator-activated receptor gamma (PPARgamma) heterodimers: intermolecular synergy requires only the PPARgamma hormone-dependent activation function.
Molecular and cellular biology 1998;18(6):3483-94.
1998: R Mukherjee; J Strasser; L Jow; PA Hoener; James R Paterniti; Richard A Heyman
RXR agonists activate PPARalpha-inducible genes, lower triglycerides, and raise HDL levels in vivo.
Arteriosclerosis, thrombosis, and vascular biology 1998;18(2):272-6.
1998: Eric D Bischoff; Marco Gottardis; T E Moon; Richard A Heyman; William W Lamph
Beyond tamoxifen: the retinoid X receptor-selective ligand LGD1069 (TARGRETIN) causes complete regression of mammary carcinoma.
Cancer research 1998;58(3):479-84.
1998: Laszlo Nagy; Vilmos A Thomazy; Richard A Heyman; Peter Davies
Retinoid-induced apoptosis in normal and neoplastic tissues.
Cell death and differentiation 1998;5(1):11-9.
1997: Shi-Yong Sun; Ping Yue; Marcia I Dawson; B Shroot; S Michel; William W Lamph; Richard A Heyman; M Teng; Roshantha A S Chandraratna; K Shudo; Waun Ki Hong; Reuben Lotan
Differential effects of synthetic nuclear retinoid receptor-selective retinoids on the growth of human non-small cell lung carcinoma cells.
Cancer research 1997;57(21):4931-9.
1997: P Fitzgerald; M Teng; R A Chandraratna; Richard A Heyman; Elizabeth A Allegretto
Retinoic acid receptor alpha expression correlates with retinoid-induced growth inhibition of human breast cancer cells regardless of estrogen receptor status.
Cancer research 1997;57(13):2642-50.
1997: Deepak S Lala; P M Syka; S B Lazarchik; D J Mangelsdorf; Keith L Parker; Richard A Heyman
Activation of the orphan nuclear receptor steroidogenic factor 1 by oxysterols.
Proceedings of the National Academy of Sciences of the United States of America 1997;94(10):4895-900.
1997: R Mukherjee; Peter Davies; Diane L Crombie; Eric D Bischoff; Rosemary M Cesario; L Jow; L G Hamann; Marcus F Boehm; C E Mondon; Alex M Nadzan; James R Paterniti; Richard A Heyman
Sensitization of diabetic and obese mice to insulin by retinoid X receptor agonists.
Nature 1997;386(6623):407-10.
1997: Elizabeth A Allegretto; Richard A Heyman
Expression and characterization of retinoid receptors in yeast.
Methods in enzymology 1997;282():25-32.
1997: D R Shalinsky; Eric D Bischoff; William W Lamph; L Zhang; Marcus F Boehm; Peter Davies; Alex M Nadzan; Richard A Heyman
A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice.
Cancer research 1997;57(1):162-8.
1996: R Mukherjee; L Jow; J Strasser; P Syka; J Rosen; Richard A Heyman
Synergistic activation of the hydratase but not the ApoA1 gene by gemfibrozil and retinoids.
Annals of the New York Academy of Sciences 1996;804():734-5.
1996: M M Gottardis; Eric D Bischoff; M A Shirley; M A Wagoner; William W Lamph; Richard A Heyman
Chemoprevention of mammary carcinoma by LGD1069 (Targretin): an RXR-selective ligand.
Cancer research 1996;56(24):5566-70.
1996: D S Lala; R Mukherjee; I G Schulman; S S Koch; L J Dardashti; Alex M Nadzan; G E Croston; R M Evans; Richard A Heyman
Activation of specific RXR heterodimers by an antagonist of RXR homodimers.
Nature 1996;383(6599):450-3.
1996: AM Standeven; Richard L Beard; Alan Johnson; Marcus F Boehm; M Escobar; Richard A Heyman; R A Chandraratna
Retinoid-induced hypertriglyceridemia in rats is mediated by retinoic acid receptors.
Fundamental and applied toxicology : official journal of the Society of Toxicology 1996;33(2):264-71.
1996: S S Canan Koch; L J Dardashti; J J Hebert; Steven White; G E Croston; K S Flatten; Richard A Heyman; Alex M Nadzan
Identification of the first retinoid X, receptor homodimer antagonist.
Journal of medicinal chemistry 1996;39(17):3229-34.
1996: L Zhang; Alex M Nadzan; Richard A Heyman; D L Love; Dale E Mais; G Croston; William W Lamph; Marcus F Boehm
Discovery of novel retinoic acid receptor agonists having potent antiproliferative activity in cervical cancer cells.
Journal of medicinal chemistry 1996;39(14):2659-63.
1996: Ana Angulo; C Suto; Richard A Heyman; Peter Ghazal
Characterization of the sequences of the human cytomegalovirus enhancer that mediate differential regulation by natural and synthetic retinoids.
Molecular endocrinology (Baltimore, Md.) 1996;10(7):781-93.
1996: Laszlo Nagy; Vilmos A Thomázy; R A Chandraratna; Richard A Heyman; Peter Davies
Retinoid-regulated expression of BCL-2 and tissue transglutaminase during the differentiation and apoptosis of human myeloid leukemia (HL-60) cells.
Leukemia research 1996;20(6):499-505.
1996: Y Kamei; Li Xu; T Heinzel; Joseph Torchia; R Kurokawa; B Gloss; S C Lin; Richard A Heyman; David W Rose; Christopher K Glass; Michael G Rosenfeld
A CBP integrator complex mediates transcriptional activation and AP-1 inhibition by nuclear receptors.
Cell 1996;85(3):403-14.
1996: D R Shalinsky; Eric D Bischoff; M L Gregory; William W Lamph; Richard A Heyman; J S Hayes; Vilmos A Thomazy; Peter Davies
Enhanced antitumor efficacy of cisplatin in combination with ALRT1057 (9-cis retinoic acid) in human oral squamous carcinoma xenografts in nude mice.
Clinical cancer research : an official journal of the American Association for Cancer Research 1996;2(3):511-20.
1996: Laszlo Nagy; M Saydak; N Shipley; S Lu; J P Basilion; Z H Yan; P Syka; R A Chandraratna; J P Stein; Richard A Heyman; Peter Davies
Identification and characterization of a versatile retinoid response element (retinoic acid receptor response element-retinoid X receptor response element) in the mouse tissue transglutaminase gene promoter.
The Journal of biological chemistry 1996;271(8):4355-65.
1996: M M Gottardis; William W Lamph; D R Shalinsky; A Wellstein; Richard A Heyman
The efficacy of 9-cis retinoic acid in experimental models of cancer.
Breast cancer research and treatment 1996;38(1):85-96.
1995: Reid P Bissonnette; Thomas Brunner; S B Lazarchik; N J Yoo; Marcus F Boehm; Douglas R Green; Richard A Heyman
9-cis retinoic acid inhibition of activation-induced apoptosis is mediated via regulation of fas ligand and requires retinoic acid receptor and retinoid X receptor activation.
Molecular and cellular biology 1995;15(10):5576-85.
1995: Marcus F Boehm; L Zhang; Lin Zhi; M R McClurg; E Berger; M Wagoner; Dale E Mais; C M Suto; J A Davies; Richard A Heyman
Design and synthesis of potent retinoid X receptor selective ligands that induce apoptosis in leukemia cells.
Journal of medicinal chemistry 1995;38(16):3146-55.
1995: D R Shalinsky; Eric D Bischoff; M L Gregory; M M Gottardis; J S Hayes; William W Lamph; Richard A Heyman; M A Shirley; T A Cooke; Peter Davies
Retinoid-induced suppression of squamous cell differentiation in human oral squamous cell carcinoma xenografts (line 1483) in athymic nude mice.
Cancer research 1995;55(14):3183-91.
1995: Laszlo Nagy; Vilmos A Thomázy; G L Shipley; L Fésüs; William W Lamph; Richard A Heyman; R A Chandraratna; Peter Davies
Activation of retinoid X receptors induces apoptosis in HL-60 cell lines.
Molecular and cellular biology 1995;15(7):3540-51.
1995: Margaret Harmon; Marcus F Boehm; Richard A Heyman; David J Mangelsdorf
Activation of mammalian retinoid X receptors by the insect growth regulator methoprene.
Proceedings of the National Academy of Sciences of the United States of America 1995;92(13):6157-60.
1995: Ana Angulo; C Suto; Marcus F Boehm; Richard A Heyman; Peter Ghazal
Retinoid activation of retinoic acid receptors but not of retinoid X receptors promotes cellular differentiation and replication of human cytomegalovirus in embryonal cells.
Journal of virology 1995;69(6):3831-7.
1995: P J Willy; Kazuhiko Umesono; Estelita S Ong; Ronald M Evans; Richard A Heyman; David J Mangelsdorf
LXR, a nuclear receptor that defines a distinct retinoid response pathway.
Genes & development 1995;9(9):1033-45.
1995: Scott M Lippman; Richard A Heyman; Jonathan M Kurie; Steven E Benner; Waun Ki Hong
Retinoids and chemoprevention: clinical and basic studies.
Journal of cellular biochemistry. Supplement 1995;22():1-10.
1994: R Kurokawa; J DiRenzo; Marcus F Boehm; J Sugarman; B Gloss; Michael G Rosenfeld; Richard A Heyman; Christopher K Glass
Regulation of retinoid signalling by receptor polarity and allosteric control of ligand binding.
Nature 1994;371(6497):528-31.
1994: C Pathirana; Richard A Heyman; S B Lazarchik
Identification of an activator of the retinoid X receptor.
Journal of natural products 1994;57(10):1458-61.
1994: Marcus F Boehm; L Zhang; B A Badea; Steven White; Dale E Mais; E Berger; C M Suto; M E Goldman; Richard A Heyman
Synthesis and structure-activity relationships of novel retinoid X receptor-selective retinoids.
Journal of medicinal chemistry 1994;37(18):2930-41.
1994: J W Lee; D D Moore; Richard A Heyman
A chimeric thyroid hormone receptor constitutively bound to DNA requires retinoid X receptor for hormone-dependent transcriptional activation in yeast.
Molecular endocrinology (Baltimore, Md.) 1994;8(9):1245-52.
1994: Marcus F Boehm; M R McClurg; C Pathirana; David J Mangelsdorf; Steven White; J Hebert; D Winn; M E Goldman; Richard A Heyman
Synthesis of high specific activity [3H]-9-cis-retinoic acid and its application for identifying retinoids with unusual binding properties.
Journal of medicinal chemistry 1994;37(3):408-14.
1993: Elizabeth A Allegretto; M R McClurg; S B Lazarchik; D L Clemm; S A Kerner; M G Elgort; Marcus F Boehm; Steven White; J W Pike; Richard A Heyman
Transactivation properties of retinoic acid and retinoid X receptors in mammalian cells and yeast. Correlation with hormone binding and effects of metabolism.
The Journal of biological chemistry 1993;268(35):26625-33.
1992: David J Mangelsdorf; U Borgmeyer; Richard A Heyman; J Y Zhou; Estelita S Ong; A E Oro; A Kakizuka; Ronald M Evans
Characterization of three RXR genes that mediate the action of 9-cis retinoic acid.
Genes & development 1992;6(3):329-44.